1177435-86-7Relevant academic research and scientific papers
Study on chemical modification and analgesic activity of N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxamide
Gao, Mengkang,Hu, Jing,Li, Qifei,Nie, Cunbin,Qian, Hai,Qiao, Yue,Qiao, Zhenrui,Wang, Qiang,Wang, Yusui,Yan, Lin
, (2020)
N-(4-Tert-butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxamide (BCTC) is a potent and extensively studied urea-based TRPV1 antagonist. Although BCTC was effective in alleviating chronic pain in rats, it showed obvious hyperthermia side-effect an
1,2,3,4-tetrahydro-9H-pyridino[3,4-b]indole transient receptor potential vanilloid 1 (TRPV1) antagonist and application thereof
-
Paragraph 0109; 0111; 0128-0132, (2019/06/13)
The invention relates to a 1,2,3,4-tetrahydro-9H-pyridino[3,4-b]indole transient receptor potential vanilloid 1 (TRPV1) antagonist or a pharmaceutically-acceptable salt thereof. The structure generalformula is shown in the specifications, in the formula,
